← daily scanner dashboard

#10 ACOG — Alpha Cognition Inc.

A2_VCP_NEAR_PIVOT | as of 2026-10-02 | automated relative priority, not a published Minervini point formula

Relative priority42.50
RS rating77.11
Fundamental strength100.00
VCP score84.13
Pivot distance1.52%
AV confirmation60.00%complete
Technical chart for ACOG

Trend Template

price_above_sma150_and_sma200PASS
sma150_above_sma200PASS
sma200_rising_1mPASS
sma50_above_sma150_and_sma200PASS
price_above_sma50PASS
price_at_least_30pct_above_52w_lowPASS
price_within_25pct_of_52w_highPASS
rs_rating_at_least_70PASS

Trend Template metrics

close9.10
sma508.93
sma1507.27
sma2006.88
sma200_1m_ago6.56
pct_above_52w_low102.22
pct_below_52w_high10.26
rs_rating77.11

VCP conditions

coherent_contraction_sequencePASS
enough_contractionsPASS
successive_ranges_inside_firstPASS
successive_depths_contractingPASS
final_contraction_tightPASS
base_depth_okPASS
resistance_area_tightPASS
volume_dryupFAIL
atr_contractingPASS
price_tightFAIL
near_pivotPASS

VCP metrics

num_contractions2.00
contraction_depths_pct[14.87, 10.17]
depth_ratios_vs_prior[0.684]
target_depth_ratio_roughly_half0.50
max_allowed_depth_ratio0.80
base_high9.75
base_low8.30
base_depth_pct14.87
base_duration_weeks3.40
resistance_spread_pct5.23
volume_dryup_ratio_10d_vs_50d0.85
atr_pct_recent6.06
atr_pct_prior7.82
atr_contraction_ratio0.77
tight_10d_range_pct13.61
raw_contraction_count11.00
raw_depths_pct[25.4, 9.68, 13.01, 11.1, 15.34, 13.29, 18.67, 13.68, 12.03, 14.87, 10.17]
final_trough_age_bars4.00
selection_reasoncoherent_current_sequence
pivot_price9.24
distance_to_pivot_pct1.52
vcp_score_pct84.13
is_vcp_candidatePASS
breakout_on_volumeFAIL

Price / volume

return_1m_pct-2.31
return_3m_pct15.19
return_6m_pct52.17
return_12m_pct23.47
weighted_12m_momentum8.54
range_10d_pct13.61
range_20d_pct17.47
avg_volume_50d129,086
dollar_volume_50d1.17M
up_down_volume_ratio_50d1.01
accumulation_days_20d3.00
distribution_days_20d4.00

Fundamental overlay criteria

eps_growth_minimumPASS
sales_growth_positive_or_betterPASS
core_data_coveragePASS
eps_acceleratingPASS
sales_acceleratingPASS
gross_margin_improvingPASS
operating_margin_improvingPASS

Minervini-oriented SEC fundamentals

eps_growth_yoy_pct51.22
eps_previous_q_yoy_growth_pct-190.91
eps_acceleration_pts242.13
eps_annual_growth_pct42.16
eps_cagr_3y_pct—
sales_growth_yoy_pct267.56
sales_previous_q_yoy_growth_pct20.66
sales_acceleration_pts246.90
sales_annual_growth_pct—
sales_cagr_3y_pct—
gross_margin_pct93.58
operating_margin_pct-127.29
pretax_margin_pct—
net_margin_pct-144.26
gross_margin_yoy_change_pts5.88
operating_margin_yoy_change_pts382.29
roe_latest_fy_pct-40.68
current_ratio9.03
debt_to_equity_pct—
cash_to_debt—
shares_outstanding—
adjusted_eps_growth_yoy_pct—
earnings_surprise_pct—
eps_estimate_revision_30d_pct—
analyst_count—
institutional_ownership_pct—
institutional_qoq_change_pct—
management_guidance_revision_pct—

SEC data quality

core_coverage_pct90.00
missing_core_metrics["shares_outstanding"]
selected_sec_tags{"accounts_payable": "us-gaap:AccountsPayableCurrent", "accounts_receivable": "us-gaap:AccountsReceivableNetCurrent", "capex": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "cash": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "cost_of_revenue": "us-gaap:CostOfRevenue", "current_assets": "us-gaap:AssetsCurrent", "current_liabilities": "us-gaap:LiabilitiesCurrent", "dividends_paid": null, "eps_basic": "us-gaap:EarningsPerShareBasic", "eps_diluted": "us-gaap:EarningsPerShareDiluted", "equity": "us-gaap:StockholdersEquity", "gross_profit": "us-gaap:GrossProfit", "inventory": "us-gaap:InventoryNet", "long_term_debt": null, "long_term_debt_current": null, "net_income": "us-gaap:NetIncomeLoss", "operating_cash_flow": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "operating_income": "us-gaap:OperatingIncomeLoss", "pretax_income": null, "r_and_d": "us-gaap:ResearchAndDevelopmentExpense", "revenue": "us-gaap:Revenues", "sga": "us-gaap:SellingGeneralAndAdministrativeExpense", "share_repurchases": null, "shares_outstanding": "dei:EntityCommonStockSharesOutstanding", "short_term_debt": null, "short_term_investments": null, "stock_based_comp": "us-gaap:ShareBasedCompensation", "total_assets": "us-gaap:Assets", "total_liabilities": "us-gaap:Liabilities", "weighted_avg_diluted_shares": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding"}
unavailable_canonical_concepts["dividends_paid", "long_term_debt", "long_term_debt_current", "pretax_income", "share_repurchases", "short_term_debt", "short_term_investments"]
warnings["Standalone Q4 income/EPS can be absent because 10-K statements are annual.", "Company-specific extension tags are not returned by CompanyFacts.", "Non-GAAP EPS, guidance, 13F ownership, Form 4 activity, and analyst estimates are separate modules."]

Reporting periods

latest_quarter_end2026-06-30
latest_quarter_filed2026-08-13
latest_fiscal_year_end2025-12-31
latest_balance_sheet_end2026-06-30

Company metadata

symbolACOG
cik1.66M
company_nameAlpha Cognition Inc.
exchange—
sic2,836
sic_descriptionBiological Products, (No Diagnostic Substances)
fiscal_year_end1,231
as_of2026-10-04
sourceSEC EDGAR CompanyFacts + Submissions

Alpha Vantage enrichment

latest_reported_date2026-08-13
latest_reported_eps-0.40
latest_estimated_eps-0.39
latest_earnings_surprise_pct-2.56
avg_earnings_surprise_4q_pct14.26
positive_earnings_surprises_4q3.00
earnings_surprise_quarters_available4.00
estimate_period2027-12-31
analyst_count_eps—
analyst_count_revenue—
eps_estimate_avg—
revenue_estimate_avg—
estimate_revision.eps_estimate_revision_up_trailing_7_days1.00
estimate_revision.eps_estimate_revision_up_trailing_30_days1.00
estimate_revision.eps_estimate_revision_down_trailing_30_days2.00
eps_revision_up_30d1.00
eps_revision_down_30d2.00
eps_revision_net_up_30d-1.00
institutional.total_institutional_holders26.00
institutional.total_institutional_shares10.49M
institutional.holders_with_increased_holdings7.00
institutional.holders_with_decreased_holdings5.00
institutional.holders_with_unchanged_holdings14.00
institutional_holder_rows26.00
institutional_total_shares10.49M
endpoints_returned["EARNINGS", "EARNINGS_ESTIMATES", "INSTITUTIONAL_HOLDINGS"]

Alpha Vantage confirmation screen

latest_earnings_surprise_positiveFAIL
average_4q_earnings_surprise_positivePASS
positive_surprise_quartersPASS
analyst_coverage_present—
eps_revision_breadth_nonnegative_30dFAIL
institutional_sponsorship_presentPASS

Alpha Vantage screen summary

statuscomplete
confirmation_score_pct60.00
available_criteria5.00
noteInformational post-Exp0 confirmation only; not part of validated Exp0 selection/ranking.

Alpha Vantage endpoint status

EARNINGScache_available
EARNINGS_ESTIMATEScache_available
INSTITUTIONAL_HOLDINGScache_available

Accepted VCP contractions

peak_datepeak_pricetrough_datetrough_pricedepth_pctdepth_ratio_vs_priorbars
2026-09-089.752026-09-168.3014.87—6.00
2026-09-179.242026-09-288.3010.170.687.00

Recent SEC filings

formfiling_dateaccession_numberprimary_document
10-Q2026-08-130001213900-26-089188ea0300175-10q_alpha.htm
8-K2026-06-230001213900-26-070903ea0295376-8k_alpha.htm
10-Q2026-05-140001213900-26-056588ea0288768-10q_alpha.htm
8-K/A2026-05-010001213900-26-050998ea028878301-8ka_alphacog.htm
8-K2026-04-200001213900-26-045668ea028707001-8k_alphacog.htm
8-K2026-04-140001213900-26-043517ea0285983-8k_alpha.htm
10-K2026-03-310001213900-26-037614ea0280314-10k_alphacog.htm
8-K2026-03-270001213900-26-035696ea0283878-8k_alpha.htm
8-K2026-03-260001213900-26-034778ea0283622-8k_alpha.htm
8-K2026-02-230001213900-26-019355ea0277868-8k_alpha.htm
8-K2026-01-150001213900-26-004765ea027312401-8k_alpha.htm
10-Q2025-11-130001213900-25-110061ea0263490-10q_alpha.htm

SEPA factors not covered by SEC + Yahoo

These remain manual or require another provider/module and are deliberately not guessed: